Stryker reported preliminary net sales at $2.2 billion for the fourth quarter, driven by a 46.8 percent increase in neurotechnology and spine sales. For the year’s end, the company reports preliminary net sales of $8.3 billion, a 13.5 percent increase over the previous year.
During the fourth quarter, the company repurchased 1.8 million shares at a cost of $83 million. In 2011, the company repurchased $622 million in shares.
Related Articles on Orthopedic Devices:
Ortho Kinematics Receives FDA Clearance on KineGraph Vertebral Motion Analyzer
56 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in December
AAOS Releases Technology Overview for Metal-on-Metal Hip Implants
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.